E

Evotec SE
XETRA:EVT

Watchlist Manager
Evotec SE
XETRA:EVT
Watchlist
Price: 7.695 EUR -2.16% Market Closed
Market Cap: 1.4B EUR
Have any thoughts about
Evotec SE?
Write Note

Wall Street
Price Targets

EVT Price Targets Summary
Evotec SE

Wall Street analysts forecast EVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVT is 14.351 EUR with a low forecast of 4.04 EUR and a high forecast of 31.5 EUR.

Lowest
Price Target
4.04 EUR
47% Downside
Average
Price Target
14.351 EUR
87% Upside
Highest
Price Target
31.5 EUR
309% Upside
Evotec SE Competitors:
Price Targets
CDXC
Chromadex Corp
1% Upside
TECH
Bio-Techne Corp
12% Upside
300759
Pharmaron Beijing Co Ltd
20% Downside
RGEN
Repligen Corp
39% Upside
4880
CellSource Co Ltd
39% Upside
LONN
Lonza Group AG
15% Upside
SEER
Seer Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Evotec SE

For the last 8 years the compound annual growth rate for Evotec SE's revenue is 25%. The projected CAGR for the next 3 years is 11%.

25%
Past Growth
11%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Evotec SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Evotec SE

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EVT's stock price target?
Price Target
14.351 EUR

According to Wall Street analysts, the average 1-year price target for EVT is 14.351 EUR with a low forecast of 4.04 EUR and a high forecast of 31.5 EUR.

What is Evotec SE's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Evotec SE's revenue is 25%. The projected CAGR for the next 3 years is 11%.

Back to Top